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Abstract
Background
Neonatal Tetanus (NT) is a preventable cause of mortality and neurological sequelae that
occurs at higher incidence in resource-poor countries, presumably because of low maternal
immunisation rates and unhygienic cord care practices. We aimed to determine changes in
the incidence of NT, characterize and investigate the associated risk factors and mortality in
a prospective cohort study including all admissions over a 15-year period at a County hospi-
tal on the Kenyan coast, a region with relatively high historical NT rates within Kenya.
Methods
We assessed all neonatal admissions to Kilifi County Hospital in Kenya (1999–2013) and
identified cases of NT (standard clinical case definition) admitted during this time. Poisson
regression was used to examine change in incidence of NT using accurate denominator
data from an area of active demographic surveillance. Logistic regression was used to in-
vestigate the risk factors for NT and factors associated with mortality in NT amongst neona-
tal admissions. A subset of sera from mothers (n = 61) and neonates (n = 47) were tested
for anti-tetanus antibodies.
Results
There were 191 NT admissions, of whom 187 (98%) were home deliveries. Incidence of NT
declined significantly (Incidence Rate Ratio: 0.85 (95% Confidence interval 0.81–0.89),
P<0.001) but the case fatality (62%) did not change over the study period (P = 0.536).
Younger infant age at admission (P = 0.001) was the only independent predictor of mortali-
ty. Compared to neonatal hospital admittee controls, the proportion of home births was
higher among the cases. Sera tested for antitetanus antibodies showed most mothers (50/
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61, 82%) had undetectable levels of antitetanus antibodies, and most (8/9, 89%) mothers
with detectable antibodies had a neonate without protective levels.
Conclusions
Incidence of NT in Kilifi County has significantly reduced, with reductions following immuni-
sation campaigns. Our results suggest immunisation efforts are effective if sustained and ef-
forts should continue to expand coverage.
Introduction
Neonatal tetanus (NT) continues to be a major cause of mortality and neurological sequelae for
survivors yet it is highly preventable using simple and inexpensive public health interventions
[1,2]. In 2013, NT was estimated to be responsible for 49,000 deaths [3], mostly in rural areas
of developing countries where most births occur at home and are often attended by unskilled
persons using unhygienic practices without aseptic postnatal care [4]. NT is estimated to con-
tribute about 2% of neonatal deaths in 2012 [5], a decrease from 7% in 2000 [4], but has a very
high case fatality rate [6,7].
Fetuses acquire passive immunity to tetanus if their mothers are adequately immunised.
Two or more doses of tetanus toxoid vaccine to the mother have been shown to reduce NT
mortality by 94% [8]. Immunisation may therefore reduce the number of NT cases to the
World Health Organization (WHO) elimination target of1 per 1000 live births in all regions,
these targets have been missed twice (1995 and 2005) [9]. However, pregnant women may not
get adequate immunisation because they cannot, or do not access antenatal care at all, or do so
late in their pregnancy [10].
Studies have shown that NT deaths are underestimated with reporting proportions as low as
5% [11]. In 2000, Kenya was among the 59 countries having 11–50% of its districts at high risk
of NT deaths [12]. Ten years later, NT was still a public health problem in 34 countries, includ-
ing Kenya. Consequently, it was among the 10 countries selected by WHO to implement a poli-
cy of three doses of tetanus toxoid in high risk areas in the year 2012. By May 2013, Kenya was
still among the 28 remaining countries yet to meet the elimination target [13].
Studies from Kenya have shown that NT has high case fatality and that those who survive
have evidence of brain damage [14,15]. We aimed to determine changes in the incidence of
NT, characterize and investigate the associated risk factors and mortality in a prospective co-
hort study including all admissions from 1999 to 2013 at a rural County hospital on the
Kenyan coast.
Methods
Study setting and population
The study was conducted in Kilifi County Hospital (KCH) [formerly Kilifi District Hospital],
the only County level hospital within the area covered by the Kilifi Health and Demographic
Surveillance System (KHDSS) [16], in Kilifi County, Coastal region. The estimated fertility rate
in KHDSS is 4.7 and the overall neonatal mortality rate was estimated at 17.1 per 1000 live
births for the period 2006–2010 [16].
KCH serves the KHDSS population, with about 4400 paediatric admissions every year.
KCH has one paediatric ward and a high dependency unit. The high dependency unit nurses
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triage all children, identifying those requiring immediate medical attention, including those
with NT. Immunoglobulin and facilities for ventilation were unavailable during the period of
the study.
Diagnosis
The diagnosis of tetanus was clinical, based on medical history and examination, determining
the presence of at least three of the following clinical findings: severe trismus, refusal to feed,
generalised muscle rigidity, opisthotonus or spontaneous tetanic spasms [17]. A full clinical ex-
amination was performed on admission, with pulse and peripheral oxygen saturation mea-
sured by fingertip pulse oximetry (Nellcor). Respiratory rate was counted over 1 minute. The
number of spasms was counted over a 5-minute period whilst the neonate lay on a bed in a
side ward. A tetanus score based upon the summation of scores on: irritability (0–2), feeding
problems (0–2), stiffness (0–3), frequency of spasms (0–3), duration of spasms (0–3), involve-
ment of limbs (0–3), stimulation of spasms (0–3), cyanosis during spasms (0,-2) and apnoea
(0–1) was calculated, with higher scores being indicative of more severe disease.
Management
Care was primarily supportive, as tetanus immunoglobulin was not available, but the umbilical
cord stump was cleaned every day with surgical spirit to reduce toxin production [18,19].
Broad spectrum antibiotics were given according to standard protocols; either intravenous
pencillin (benzylpenicillin (50mg/kg 6 hourly) or ampicillin (50mg/kg 6 hourly)) with genta-
mycin (7.5mg/kg once daily IV) or metronidazole (7.5mg/kg 8 hourly).
Patients with NT were nursed in a quiet room on a bed covered with a cradle and blankets
to protect the baby from light. During the period of severe spasms IV fluids were given at rate
of 150–200mls/kg/day, but when these stopped breast milk was given through a nasogastric
(ng) tube. Neonates were sedated with diazepam (0.1–0.25 mg/kg IV) and phenobarbital
(15mg/kg loading dose ng, 5–8 mg/kg maintenance 12 hrly ng). Chlorpromazine (0.5 mg/kg/dose
6 hrly ng) was added if required due to persisting spasms. Oxygen was given when saturation
dropped below 95% and suction was performed when necessary. With improvement, identified
through daily monitoring and scoring of spasms, sedation was reduced and feeding recom-
menced prior to discharge.
Investigations and laboratory methods for clinical investigations
Blood samples were taken within one hour of admission. Laboratory measurements included
full blood count (Beckman Coulter Inc USA), electrolytes (Chriron Diagnositics 614 Na+/K+
analyser, Ciba Corning, UK), creatinine (Creatinine Analyzer 2, Beckman, USA) and glucose
(Analox GM 6, London UK). Blood and cerebrospinal fluid (CSF) were taken for microscopy
and bacterial culture (Bactec, BD).
Measurement of antitetanus antibody levels by ELISA
Plasma was collected from blood drawn from the neonates with tetanus and their mothers and
stored at -20°C for the measurement of IgG and IgG1 specific for tetanus toxoid using a stan-
dard enzyme-linked immunosorbent assay (ELISA). Briefly, tetanus toxoid protein (National
Institute for Biological Standards and Control (NIBSC, Hertfordshire, England) was coated on
standard 96 well ELISA plates and blocked with phosphate buffered saline with 0.05% Tween-
20 (Sigma, Dorset, England) and 4% non-fat dry milk. Duplicate serial dilutions of each serum/
plasma sample were then added to wells, incubated and then washed. Bound antibody to
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tetanus toxoid was detected with anti-human IgG or anti-human IgG1 conjugated to horserad-
ish peroxidise (Dako, Glostrup, Denmark), followed by O-phenylenediamine (Sigma). Quanti-
fication was undertaken by comparison of values in the log-linear range to those of antitetanus
antibody standard 26/388 [20] run in the same assay; standard was generously provided by Dr.
D. House, Imperial College, London.
Statistical analysis
Analyses were performed using STATA (Version 12; STATA Corp, College Station, TX, USA).
Descriptive statistics were first undertaken and incidence and risk factors assessed as
described below.
Incidence of NT over time
Wemeasured the incidence as the number of NT cases for every 1000 live births per year.
Since we were not sure if the unregistered cases [neonates not already identified within the
KHDSS system] came from within the KHDSS we considered both scenarios by treating them
as either from within and outside the KHDSS. Cases that were explicitly stated to be from out-
side the KHDSS were not used in the calculation of incidence. However, unless it is explicitly
stated otherwise, we refer to incidence as that arising from cases within the KHDSS. Data on
live births in KHDSS formed the denominator, with reliable data on these taken from KHDSS
for the period 2004 to 2012. We fitted a simple linear regression model to these data to predict
the unknown number of live births for the period 1999 to 2003. Poisson regression was used to
examine the secular trend of NT admissions with logarithm of the number of live births taken
as an offset in the model.
Factors associated with NT
Four hundred hospitalised neonatal controls admitted to KCH during the study period were
randomly selected from the clinical database for the nested case-control study. Clinical data on
place of birth, weight at admission and oxygen saturation at admission was obtained from rou-
tine clinical surveillance data. Multivariable logistic model was used to determine which of
these factors were associated with admission with NT rather than other conditions. To identify
the independent predictors, we first performed univariable associations and included all the
variables with univariable P-value (P)<0.20 in the final multivariable model.
Factors associated with death in NT admittees
For neonates residing within the KHDSS, survival data were obtained from the KHDSS. Yearly
case fatality risk was calculated as the percentage of cases that died. Multivariable logistic re-
gression was used to determine factors associated with death in NT by including all the explan-
atory variables with P<0.20 in the univariable analysis together in one model. Variables
considered included: maternal factors (education of the mother and immunisation status), de-
mographic factors (sex and age in days), clinical features (heart rate, respiratory rate, umbilicus
(inflamed or not), prostration (present/absent), number of spasms, oxygen saturation (defined
as low if below 95%) and presence or absence of complications during delivery, and laboratory
investigations (hypoglycaemia defined as blood sugar<2.5mmol/L(<2.5kg), magnesium con-
centration, sodium level, creatinine level, white blood cell count and haemoglobin).
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Antitetanus antibodies
The plasma from 47 infants admitted to Kilifi County Hospital for tetanus between May 1999
and September 2003 and from 61 mothers were tested for IgG antibodies specific for tetanus
toxoid (anti-TT IgG). All infant samples that were tested had a matching maternal sample. We
thus tested maternal samples with detectable antitetanus antibody for antitetanus IgG1. We did
not have permission to test for HIV or examine their placenta during this period.
Ethics Statement
We obtained informed written consent from the neonates’ parent/guardian. The study was ap-
proved by the Kenya Medical Research Institute (KEMRI) and the KEMRI National Ethics Re-
view Committee (SCC Number: 1592).
Results
Incidence of NT over time
During the 15-year period, 191 neonates with NT were admitted to Kilifi County Hospital
(KCH), of whom 118/189 (62.4%) were males. Thirty-four (17.8%) were admitted from outside
the KHDSS while 50 (26.2%) were assumed to be unregistered because the location was un-
known (S1 table). The remainder (107, 56.0%) were from within the KHDSS. The estimated in-
cidence consistently declined from 2.3 to 0.0 per 1000 live births in between 1999 and 2013
(Incidence Rate Ratio: 0.85 (95% Confidence Interval (95% CI) 0.81–0.89), P<0.001) (Fig 1)
(there were zero NT admissions in 2013), with reductions in incidence appearing after immu-
nisation campaigns for women of childbearing age conducted by the Ministry of Health in
2002 and 2008 [21]. An additional campaign in 2006 targeted school-age girls [21], and its ef-
fect may therefore not be apparent for 5–10 years. A similar pattern of incidence is observed
when unregistered cases are considered (IRR: 0.89 (95% CI 0.86–0.93), P<0.001) (Fig 1). Only
in the years 2010, 2012 and 2013 were the upper limits of the 95% CI within the WHO target of
less than one case per 1,000 live births.
Characteristics of NT cases at admission
At admission 78/173 (45.1%) neonates with NT had inflamed cord stumps (Table 1). The me-
dian number of spasms experienced by the children every five minutes was 5 (Inter quartile
range (IQR): 2–10). The median age and weight at admission were 7 days (IQR: 5–9) and 2.5kg
(IQR: 2.3–2.8) respectively (S2 Table).
Most mothers 85/128 (66.4%) had never enrolled in school whilst 38/128 (29.7%) had pri-
mary level education, 5/128 (3.9%) secondary and none had post-secondary. Of 63 women for
whom data were available, 41 (65%) were primigravidae. All mothers had a spontaneous vagi-
nal delivery with only 4/186 (2.2%) having complications: one in hospital and three home
births. There were only 4/187 (2.2%) hospital births. Of 158 cases for which data was recorded,
102 (65%) reported using nonsterile or harmful substance on the umbilicus (Table 1).
Antitetanus antibodies
Of the 61 mothers tested, 11 (18%) had levels of antitetanus antibody above the limit of detec-
tion of our assay (~0.03 IU/ml). Approximately one third (4/11) of these mothers had antiteta-
nus antibodies levels at or above ~0.2 IU/ml, the range in which ELISA levels correlate with
in vitro neutralisation levels [6,7]. Sporadic cases of tetanus disease occur in individuals with
>0.2 IU/ml [6,7,22,23], possibly because low affinity antibodies are measured, but protect
poorly [7]. The four mothers with levels0.2 IU/ml all had levels in the range of 0.2–1.0 IU/ml.
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The seven mothers with low levels (<0.2 IU/ml) all had levels in the range 0.03–0.1 IU/ml.
Only one infant out of 47 (2%) with NT had detectable antitetanus antibodies in their blood
(0.5 IU/ml), a child of a mother who had IgG level of 0.04 IU/ml. Thus, of the nine mothers
with detectable antitetanus IgG and a paired child’s sample, eight had children with no detect-
able antitetanus IgG. We thus assessed the levels of maternal antitetanus IgG1. All four of the
mothers with high antitetanus antibodies levels (0.1 IU/ml) had detectable IgG1, the subtype
of IgG that most easily crosses the placenta to the fetus [24]. Of the mothers with low antiteta-
nus antibodies levels (<0.1 IU/ml), 5/7 were tested for IgG1; four were negative and the fifth
had low/equivocal levels.
The presence of antitetanus IgG only partially matched self-reported immunisation status:
of the mothers lacking detectable antitetanus IgG, 30% (15/50) reported receiving at least one
dose of tetanus vaccine. Of these 15, seven (14%) reported receiving only one or two doses,
consistent with antibody levels decaying after insufficient immunisation. Among the mothers
Fig 1. Incidence and case fatality of neonatal tetanus in Kilifi County Hospital. Incidence was computed as the number of Neonatal Tetanus (NT) cases
within the KHDSS divided by the number of live births in that year. There were zero NT admissions in 2013 and therefore no deaths. NT campaigns started in
2002 in an effort by the Kenya Ministry of Health to abate NT. Major campaigns to women of child bearing age were carried out in 2002, 2008 and 2013 as
shown by the arrows. The red dashed line is theWHO target of less than one NT cases per 1000 live births. The case fatality is the proportion of neonatal
tetanus admissions discharged dead.
doi:10.1371/journal.pone.0122606.g001
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with detectable IgG, 73% (8/11) reported being immunised with<3 (5, 45%) or3 (3, 27%)
doses. Several possible reasons could explain the lack of detectable antitetanus IgG in the 15 re-
porting vaccination but did not have detectable antitetanus IgG levels: (i) they were mistaken
about whether or not they were vaccinated against tetanus, (ii) they had immune responses
that waned over time because of insufficient vaccination, (iii) they were given ineffective vac-
cines, perhaps with an interrupted cold chain [25,26] and/or (iv) they were non-responders.
Factors associated with NT compared to hospital controls
We compared vital statistics of NT infants to those of 400 randomly selected neonatal admit-
tees to KCH during the same time period. From the univariable logistic regression, NT was as-
sociated with home delivery, low blood oxygen saturation (<95%) and low weight at
admission (<2.5kg), but was not associated with sex (Table 2). These associations remained
significant in the multivariable logistic regression.
Table 1. Characteristics of children admitted with neonatal tetanus.
Survived Died
N/mean %/SD N/mean %/SD
Overall 73 38% 118 62%
Maternal features
Mothers not educated** 10/43 23.3% 33/85 38.8%
Mother not immunized by self-reporting 31/61 50.8 65/112 58.0
Demographic features
Male 49/72 68.1% 69/117 59.0%
Age, days—median (IQR)a 10 8–13 6 5–7
Clinical features
Heart rate (per minute)* 167.4 4.0 165.8 3.3
Respiratory rate (per minute)* 60.6 2.6 64.7 2.1
Inﬂamed umbilicus 22/66 33.3% 56/107 52.3%
Prostration 20/33 60.6% 50/60 83.3%
Number of Spasms* 4.15 3.1 6.9 5.5
NT score* 13.3 0.4 14.9 0.4
Low oxygen saturation (<95%) 16/66 24.2% 59/107 55.1%
Complication during delivery 1/70 1.4% 3/116 2.6%
Laboratory Investigations
Hypoglycaemia (<2.5mmol/L) 7/33 21.2% 26/61 42.6%
Magnesium concentration (mmol/l)* 0.8 0.4 0.8 0.2
Sodium (mmol/l)* 145.1 8.3 143.5 6.4
Creatinine (μmol/l)* 99.2 70.9 94.1 45.2
White cell count (103/μl)* 13.0 4.5 13.0 4.9
Haemoglobin (g/dl)* 15.1 2.6 15.6 3.2
* indicates that mean and standard deviation are shown since they are continuous variables.
**Mothers education was scored as not educated those who have never been to school and educated if they have been to school.
a age in days at admission, median and interquartile ranges are shown, data available for 182 cases.
doi:10.1371/journal.pone.0122606.t001
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Outcomes and Risk factors on admission to hospital for death
Out of the 191 NT babies that were admitted, 73 (38.2%) were discharged alive. The case fatali-
ty was therefore 61.8%, and did not vary significantly over the 14 years (P = 0.536) (Fig 1). Age
at admission, presence of inflamed umbilicus, prostration, number of spams per 5 minutes, NT
score and presence of hypoglycaemia were all associated were all significantly associated with
death in the univariable analysis (Table 3). Eight variables with P<0.20 in the univariable anal-
ysis were included in the multivariable logistic model to identify the factors which were
Table 2. Factors associated with neonatal tetanus cases compared with hospital controls*.
Cases Controls Univariable analysis Multivariable analysis
N % N % OR(95%CI) P value OR(95%CI) P value
Home delivery 183/187 97.9 307/390 78.7 12.37 (4.46,34.30) <0.001 14.67 (5.11,42.06) <0.001
Male 118/189 62.4 235/399 58.9 1.16 (0.81,1.16) 0.414 - -
Low weight at admission (<2.5kg) 35/191 18.3 29/400 7.3 2.87 (1.70,4.86) <0.001 3.19 (1.76,5.08) <0.001
Low oxygen saturation (<95%) 75/191 39.3 66/400 16.5 3.27 (2.21,4.84) <0.001 3.29 (2.15,5.01) <0.001
*Logistic regression was used to investigate the factors associated with death among the neonatal tetanus admittees.
doi:10.1371/journal.pone.0122606.t002
Table 3. Univariable andmultivariable analysis of the factors associated with death in children with neonatal tetanus*.
Univariable analysis Multivariable analysis
OR (95%CI) P value OR (95%CI) P value
Overall
Maternal features
Mothers not educated 2.09 (0.91–4.81) 0.081 0.73 (0.18–2.97) 0.662
Mother not immunized by self-reporting 1.34 (0.72–2.50) 0.362 - -
Demographic features
Male 0.67 (0.36–1.25) 0.212 - -
Age in days 0.73 (0.65–0.83) <0.001 0.61 (0.46–0.82) 0.001
Clinical features
Heart rate (per minute) 1.00 (0.99–1.01) 0.759 - -
Respiratory rate (per minute) 1.01 (0.99–1.03) 0.217 - -
Inﬂamed umbilicus 2.20 (1.16–4.15) 0.016 1.57 (0.45–5.41) 0.476
Prostration 3.25 (1.23–8.61) 0.018 1.30 (0.33–5.16) 0.713
Number of Spasms 1.15 (1.04–1.26) 0.007 - -
NT score 1.15 (1.04–1.27) 0.006 1.11 (0.92–1.34) 0.284
Low oxygen saturation (<95%) 3.56 (1.84–6.90) <0.001 1.40 (0.35–5.58) 0.876
Complication during delivery 1.83 (0.19–8.0) 0.603 - -
Laboratory Investigations
Hypoglycaemia (<2.5mmol/L) 2.76 (1.04–7.33) 0.042 4.80 (0.87–26.57) 0.072
Magnesium (mmol/l) 2.16 (0.01–506.19) 0.783 - -
Sodium (mmol/l) 0.97 (0.91–1.03) 0.317 - -
Creatinine (μmol/l) 1.00 (0.99–1.00) 0.680 - -
White cell count (103/μl) 1.00 (0.91–1.09) 0.990 - -
Haemoglobin (g/dl) 1.06 (0.92–1.23) 0.414 - -
*In the multivariable logistic model, eight variables with a p-value<0.20 were considered in identifying the independent risk factors for death. Frequency of
spasms was not included in the multivariable model as it was highly correlated with neonatal tetanus score (NT score).
doi:10.1371/journal.pone.0122606.t003
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independently associated with death. Presence of maternal antitetanus IgG was not associated
with risk of neonatal death: (62% (31/50) vs 55% (6/11), nor did reported antitetanus immuni-
sation (Table 3). This suggests that antibody in the infant at levels below the limit of detection
of our assay transferred from the mother did not play a major role in protecting children from
death. Frequency of spasms was not included in the multivariable model because it was highly
correlated with and partially derived from NT score. Age in days at admission (OR = 0.73, 95%
CI 0.65–0.83, P = 0.001) was the only factor found to be independently associated with mortali-
ty (Table 3), with younger neonates having the highest odds for death.
Discussion
This study examined the incidence and outcomes of NT based on hospital admissions in a
carefully monitored health and demographic surveillance site in rural Kenya, over a long peri-
od of time (15 years). There was a marked decline in incidence over this period (1999–2013)
with the point estimates of incidence for the last five years (2009–2013) being<1 case per 1000
live births per year. The proportion of male cases was significantly higher than the expected
50% (χ2 = 5.95, P = 0.015), as reported in other studies [21,27,28], but not higher than the pro-
portion of males in our neonatal hospital controls from KCH (Table 2). A large population
study suggests that males have a higher risk of severe bacterial infections in the neonatal period
[29], possibly due to greater biological susceptibility.
Among NT cases, younger infant age at admission was the only factor independently associ-
ated with mortality. Earlier presentation with disease may be due to higher inocula of Clostridi-
um tetani bacteria, and/or younger infants may be physiologically at higher risk of death
[27,30].
Changes in incidence over time
Reductions in incidence of NT over time can be ascribed to several factors. First, although the
majority of births in sub-Saharan Africa still occur at home, the numbers of hospital deliveries
(where births are attended by skilled attendants) are increasing. From the 2008–2009 Kenyan
Demographic and Health survey, it was estimated that 44% of the total Kenyan births occur in
the hospital [31]. In Kilifi, about 40% of births are estimated to occur at home [21]. However,
in Kilifi, over a 19-year period, (1989 to 2008), hospital births have almost doubled [15], while
the population rose only by 32% in the KHDSS from 2001 to 2011 [16], suggesting that the pro-
portion of hospital births is increasing. Deliveries in health facilities are more likely to use anti-
sepsis, decreasing the likelihood of NT. In support of this idea, only 2% of NT cases were born
at a health care facility. In a prior study, home deliveries were also associated with NT [32].
These associations with home deliveries may be related to the use of unsterilized instruments
to cut the cord, coupled with applying non-sterile after-birth substances to cauterize the un-
healed cord stump [28,33,34]. The use of unclean delivery and cord care practices may be relat-
ed to low maternal education levels [35], as suggested by the apparently high rate of mothers
with low levels of education. A review done in Kilifi, Kenya between 2004 and 2007 found an
increasing incidence of NT cases (0.6 to 1 per 1000 live births) [21]. However, that study did
not attempt to assess the statistical significance of this trend, and that small trend runs counter
to the overall trend in our larger data set.
Importantly, increased immunisation coverage of women of child-bearing age received
TT5, likely contributed. Decreases in incidence follow immunisation campaigns from the
Kenya Ministry of Health in 2002, 2008 and 2013 which targeted women of child bearing age.
2006 focussed on school going children (<15 years) and the effect would be expected to be ap-
parent few years later. The sustained drop in incidence from 2009 may result from reaching a
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threshold of better immunisation coverage and/or from external factors such as increasing ease
of transportation and urbanisation leading to changes in lifestyle, health-seeking behaviour
and likelihood of delivering in a health care facility [36]. Anecdotal reports indicate that the
early antitetanus immunisation campaigns targeting women of childbearing age suffered from
misconceptions that family planning drugs were to be included with the immunisations and
that these misconceptions resulted in low uptake. This included the 2002 tetanus immunisation
campaign in the Coastal region, which includes Kilifi County [37]. We were aware at the time
of similar anecdotes from local Ministry of Health workers participating in that campaign in
Kilifi County. These misconceptions may have lessened over time; if so, the later campaigns
may have been more successful.
Antitetanus antibodies
Most mothers of neonates with tetanus we tested (50/61, 82%) did not have detectable levels of
antitetanus antibody in their blood. Among the minority of women that did have measurable
antitetanus antibody, all but one failed to transfer antibody that was detectable in the admission
sample of the neonatal case. One infant had detectable antitetanus antibody above 0.1 IU/ml,
which is usually associated with protection. In addition, there are reports in the literature of
one or two dozen cases of patients with tetanus who had>0.1 IU/ml [6,23], suggesting that
antitetanus antibodies, at least as measured by ELISA do not always protect from tetanus. It is
thought that ELISA may also detect antibodies that are not necessarily protective [6].
Of the nine mothers with detectable antitetanus antibody and a paired child’s blood sample,
eight failed to transfer antitetanus antibody at a level detectable on admission. This proportion
of failures appears unusually high. It seems clear that by selecting infants with NT, we may
have selected for those who did not receive antitetanus antibodies from their mothers, and the
proportion of failures is presumably lower in the general population. The mechanism of this
failure is unclear. We measured antitetanus IgG1 levels because IgG1 is the subtype of antibody
most readily transferred across the placenta [24]. Antitetanus IgG1 was detected in all 4 moth-
ers with high antitetanus antibody levels that did not transfer detectable antitetanus antibody
to her infant, yet in none of the mothers with low antitetanus antibody levels, including the
mother of the one child found with antitetanus antibodies. We presume that this reflects the
detection limit of our IgG1 assay, and suggests that failure to produce IgG1 is not a mechanism
of failure to transfer antibody to the foetus in this population. The transfer of antibody to the
foetus during pregnancy may be impaired by placental malaria [38–40] or HIV infection of the
mother [41–43]. We were not able to assess mothers for either HIV status or for placental ma-
laria infection. However, it is plausible that either of these infections may have influenced ma-
ternal transfer of antibody during pregnancy.
Case fatality and risk factors
High case fatality for NT is common [29], especially in resource-poor areas where there are no
facilities for ventilation, poor glucose monitoring and intravenous antitetanus immunoglobulin
is not available. In contrast in high income regions, where cases are extremely rare, survival has
improved greatly due to intensive care facilities [28,44]. Case fatality in this study is lower than
historical data for Kilifi [21,45], possibly due to improved care due to the high dependency unit
and the proximity of a research facility with more skilled staff.
Those who died were significantly younger than those who survived. We and others [27,30]
speculate that the shorter incubation period may be related to larger initial innocula with Clos-
tridium tetani bacteria, and/or younger infants may be at higher risk of death. There is little in-
dependent confirmation for this conclusion.
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Strengths and Limitations
This study analyses a relatively large number of NT cases (191) over a long period of time (15
years) in Kilifi County in coastal Kenya, a region with historically high incidence of neonatal
tetanus. Although this study used reliable live births estimates [16], the incidence may have
been underestimated because it only included NT cases admitted to the hospital.
Conclusions
NT incidence has dropped over the last 15 years in this rural region of Kenya. This achieve-
ment is contemporaneous with vaccination campaigns and with an apparent increase in the
rate at which delivering mothers turn to health care facilities for birth. These gains should be
built on. If these changes are sustained and apply to the rest of the country, Kenya is well on its
way to reaching the WHO elimination goal. Global elimination of this fatal disease is achiev-
able, and should be expedited, as we seek to reduce the substantial burden of neonatal
mortality worldwide.
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